Remi Gaston-Dreyfus's Net Worth
-$12.3 Million
Who is Remi Gaston-Dreyfus?
Remi Gaston-Dreyfus does not have any significant net worth to report based on the numbers we have. This is based on reported shares in Bionik Laboratories Corp..
SEC CIK
Remi Gaston-Dreyfus's CIK is 0001716639
Past Insider Trading and Trends
2019 was Remi Gaston-Dreyfus's most active year for acquiring shares with 6 total transactions. Remi Gaston-Dreyfus's most active month to acquire stocks was the month of February. 2021 was Remi Gaston-Dreyfus's most active year for disposing of shares, totalling 2 transactions. Remi Gaston-Dreyfus's most active month to dispose stocks was the month of June. 2018 saw Remi Gaston-Dreyfus paying a total of $7,930,193.77 for 134,672,664 shares, this is the most they've acquired in one year. In 2021 Remi Gaston-Dreyfus cashed out on 120,759 shares for a total of $0.00, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Bionik Laboratories Corp. No price found
InvestorRemi Gaston-Dreyfus owns 152,209,412 units of Common Stock and 6,517,958 units of Common Stock, par value $0.001 per share. From 2017 to 2023 Remi Gaston-Dreyfus acquired a total of 138,736,373 shares in Bionik Laboratories Corp. at a cost of $12,325,163.33.
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| +170.97% | 3.1M |
$0.60 | $1,861,726.80 | 4.92M |
Jun 13
| |||
Form 4
| +11.05% | 180.56K |
$0.60 | $108,333.00 | 1.81M |
Jun 9
| |||
Form 4
| +5.06% | 77.89K |
$9.50 | $739,926.50 | 1.62M |
Mar 31
| |||
Form 4
| +8.16% | 120.76K |
—
|
—
| 1.6M |
Jul 15
| |||
Form 4
| +4.32% | 61.26K |
—
|
—
| 1.48M |
Mar 29
| |||
Form 4
| +10.57% | 135.56K |
—
|
—
| 1.42M |
Mar 26
| |||
Form 4
| +0.39% | 5K |
—
|
—
| 1.28M |
Nov 25
| |||
Form 4
| +6.34% | 76.22K |
$6.80 | $518,330.00 | 1.28M |
Sep 30
| |||
Form 4
| +9.71% | 106.36K |
$3.76 | $399,906.08 | 1.2M |
Aug 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jul 26
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
May 31
| |||
Form 4
| +21.97% | 197.23K |
$3.89 | $766,747.18 | 1.1M |
Mar 28
| |||
Form 4
| +47.66% | 43.47M |
$0.05 | $2,229,936.46 | 134.67M |
Jul 24
| |||
Form 4
| +20.86% | 15.74M |
$0.06 | $983,795.50 | 91.2M |
Jun 13
| |||
Form 4
| +100.00% | 75.46M |
$0.06 | $4,716,461.81 | 150.93M |
Mar 31 - Mar 31
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||